Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Integration of molecular typing results into tuberculosis surveillance in Germany-A pilot study.

Andrés M, Göhring-Zwacka E, Fiebig L, Priwitzer M, Richter E, Rüsch-Gerdes S, Haas W, Niemann S, Brodhun B.

PLoS One. 2017 Nov 22;12(11):e0188356. doi: 10.1371/journal.pone.0188356. eCollection 2017.

2.

Contact investigation after a fatal case of extensively drug-resistant tuberculosis (XDR-TB) in an aircraft, Germany, July 2013.

An der Heiden M, Hauer B, Fiebig L, Glaser-Paschke G, Stemmler M, Simon C, Rüsch-Gerdes S, Gilsdorf A, Haas W.

Euro Surveill. 2017 Mar 23;22(12). pii: 30493. doi: 10.2807/1560-7917.ES.2017.22.12.30493.

3.

New Mycobacterium tuberculosis Complex Sublineage, Brazzaville, Congo.

Malm S, Linguissi LS, Tekwu EM, Vouvoungui JC, Kohl TA, Beckert P, Sidibe A, Rüsch-Gerdes S, Madzou-Laboum IK, Kwedi S, Penlap Beng V, Frank M, Ntoumi F, Niemann S.

Emerg Infect Dis. 2017 Mar;23(3):423-429. doi: 10.3201/eid2303.160679.

4.

A joint cross-border investigation of a cluster of multidrug-resistant tuberculosis in Austria, Romania and Germany in 2014 using classic, genotyping and whole genome sequencing methods: lessons learnt.

Fiebig L, Kohl TA, Popovici O, Mühlenfeld M, Indra A, Homorodean D, Chiotan D, Richter E, Rüsch-Gerdes S, Schmidgruber B, Beckert P, Hauer B, Niemann S, Allerberger F, Haas W.

Euro Surveill. 2017 Jan 12;22(2). pii: 30439. doi: 10.2807/1560-7917.ES.2017.22.2.30439.

5.

Ethambutol-resistance testing by mutation detection using MTBDRsl.

Margaryan H, Rüsch-Gerdes S, Hayrapetyan A, Mirzoyan A.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S50. doi: 10.1016/j.ijmyco.2016.06.007. Epub 2016 Jul 4.

6.

Tuberculosis Treatment Outcome and Drug Resistance in Lambaréné, Gabon: A Prospective Cohort Study.

Bélard S, Remppis J, Bootsma S, Janssen S, Kombila DU, Beyeme JO, Rossatanga EG, Kokou C, Osbak KK, Obiang Mba RM, Kaba HM, Traoré AN, Ehrhardt J, Bache EB, Flamen A, Rüsch-Gerdes S, Frank M, Adegnika AA, Lell B, Niemann S, Kremsner PG, Loembé MM, Alabi AS, Grobusch MP.

Am J Trop Med Hyg. 2016 Aug 3;95(2):472-80. doi: 10.4269/ajtmh.15-0668. Epub 2016 Jun 27.

7.

First national survey of anti-tuberculosis drug resistance in Azerbaijan and risk factors analysis.

Alikhanova N, Akhundova I, Seyfaddinova M, Mammadbayov E, Mirtskulava V, Rüsch-Gerdes S, Bayramov R, Suleymanova J, Kremer K, Dadu A, Acosta CD, Harries AD, Dara M.

Public Health Action. 2014 Oct 21;4(Suppl 2):S17-23. doi: 10.5588/pha.14.0049.

8.

Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs.

Barrera L, Cooreman E, de Dieu Iragena J, Drobniewski F, Duda P, Havelkova M, Hoffner S, Kam KM, Kim SJ, Labelle S, Lambregts K, Leimane V, Nunn P, Ramsay A, Raviglione M, Rich M, Ridderhof J, Rodrigues F, Rüsch-Gerdes S, Salfinger M, Scholten J, Selvakumar N, Shinnick T, Shul'gina M, Šķenders G, Sloutsky A, Small P, Van Deun A, Varaine F, Yagui M, Vincent V, Weyer K, Wright A, Zignol M.

Geneva: World Health Organization; 2008.

9.

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage.

Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S, Willery E, Blum MG, Rüsch-Gerdes S, Mokrousov I, Aleksic E, Allix-Béguec C, Antierens A, Augustynowicz-Kopeć E, Ballif M, Barletta F, Beck HP, Barry CE 3rd, Bonnet M, Borroni E, Campos-Herrero I, Cirillo D, Cox H, Crowe S, Crudu V, Diel R, Drobniewski F, Fauville-Dufaux M, Gagneux S, Ghebremichael S, Hanekom M, Hoffner S, Jiao WW, Kalon S, Kohl TA, Kontsevaya I, Lillebæk T, Maeda S, Nikolayevskyy V, Rasmussen M, Rastogi N, Samper S, Sanchez-Padilla E, Savic B, Shamputa IC, Shen A, Sng LH, Stakenas P, Toit K, Varaine F, Vukovic D, Wahl C, Warren R, Supply P, Niemann S, Wirth T.

Nat Genet. 2015 Mar;47(3):242-9. doi: 10.1038/ng.3195. Epub 2015 Jan 19.

PMID:
25599400
10.

Inactivation of Mycobacterium bovis ssp. caprae in high-temperature, short-term pasteurized pilot-plant milk.

Hammer P, Richter E, Rüsch-Gerdes S, Walte HG, Matzen S, Kiesner C.

J Dairy Sci. 2015 Mar;98(3):1634-9. doi: 10.3168/jds.2014-8939. Epub 2015 Jan 15.

PMID:
25597969
11.

Cost of multi drug resistance tuberculosis in Germany.

Diel R, Nienhaus A, Lampenius N, Rüsch-Gerdes S, Richter E.

Respir Med. 2014 Nov;108(11):1677-87. doi: 10.1016/j.rmed.2014.09.021. Epub 2014 Oct 15.

12.

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.

Miotto P, Cabibbe AM, Feuerriegel S, Casali N, Drobniewski F, Rodionova Y, Bakonyte D, Stakenas P, Pimkina E, Augustynowicz-Kopeć E, Degano M, Ambrosi A, Hoffner S, Mansjö M, Werngren J, Rüsch-Gerdes S, Niemann S, Cirillo DM.

MBio. 2014 Oct 21;5(5):e01819-14. doi: 10.1128/mBio.01819-14.

13.

Genetic characterization of German Mycobacterium avium strains isolated from different hosts and specimens by multilocus sequence typing.

Kolb J, Hillemann D, Möbius P, Reetz J, Lahiri A, Lewin A, Rüsch-Gerdes S, Richter E.

Int J Med Microbiol. 2014 Nov;304(8):941-8. doi: 10.1016/j.ijmm.2014.06.001. Epub 2014 Jun 28.

PMID:
25091874
14.

Characterisation of pyrazinamide-resistant Mycobacterium tuberculosis strains isolated in Poland and Germany.

Napiórkowska A, Rüsch-Gerdes S, Hillemann D, Richter E, Augustynowicz-Kopeć E.

Int J Tuberc Lung Dis. 2014 Apr;18(4):454-60. doi: 10.5588/ijtld.13.0457.

PMID:
24670702
15.

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.

Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Günther G, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Rüsch-Gerdes S, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM; TBNET.

Eur Respir J. 2014 Jul;44(1):23-63. doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.

16.

Multilocus sequence typing scheme for the Mycobacterium abscessus complex.

Macheras E, Konjek J, Roux AL, Thiberge JM, Bastian S, Leão SC, Palaci M, Sivadon-Tardy V, Gutierrez C, Richter E, Rüsch-Gerdes S, Pfyffer GE, Bodmer T, Jarlier V, Cambau E, Brisse S, Caro V, Rastogi N, Gaillard JL, Heym B.

Res Microbiol. 2014 Feb-Mar;165(2):82-90. doi: 10.1016/j.resmic.2013.12.003. Epub 2013 Dec 31.

PMID:
24384536
17.

Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients.

Merker M, Kohl TA, Roetzer A, Truebe L, Richter E, Rüsch-Gerdes S, Fattorini L, Oggioni MR, Cox H, Varaine F, Niemann S.

PLoS One. 2013 Dec 6;8(12):e82551. doi: 10.1371/journal.pone.0082551. eCollection 2013.

18.

[Recommendations for diagnosis and treatment of nontuberculous mycobacterioses of the German Central Committee against tuberculosis and the German Respiratory Society].

Schönfeld N, Haas W, Richter E, Bauer TT, Bös L, Castell S, Hauer B, Magdorf K, Matthiessen W, Mauch H, Reuss A, Rüsch-Gerdes S, Zabel P, Dalhoff K, Schaberg T, Loddenkemper R.

Pneumologie. 2013 Nov;67(11):605-33. doi: 10.1055/s-0033-1344790. Epub 2013 Nov 6. German.

19.

First evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countries.

Hillemann D, Hoffner S, Cirillo D, Drobniewski F, Richter E, Rüsch-Gerdes S; Baltic-Nordic TB- Laboratory Network; TB PAN-NET; ECDC ERLN-TB Networks.

PLoS One. 2013 Oct 11;8(10):e76765. doi: 10.1371/journal.pone.0076765. eCollection 2013.

20.

Occurrence of rpoB mutations in isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis isolates from Germany.

Andres S, Hillemann D, Rüsch-Gerdes S, Richter E.

Antimicrob Agents Chemother. 2014;58(1):590-2. doi: 10.1128/AAC.01752-13. Epub 2013 Oct 21.

21.

Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study.

Roetzer A, Diel R, Kohl TA, Rückert C, Nübel U, Blom J, Wirth T, Jaenicke S, Schuback S, Rüsch-Gerdes S, Supply P, Kalinowski J, Niemann S.

PLoS Med. 2013;10(2):e1001387. doi: 10.1371/journal.pmed.1001387. Epub 2013 Feb 12.

22.

[Tuberculosis infection control - recommendations of the DZK].

Ziegler R, Just HM, Castell S, Diel R, Gastmeier P, Haas W, Hauer B, Loytved G, Mielke M, Moser I, Nienhaus A, Richter E, Rüden H, Rüsch-Gerdes S, Schaberg T, Wischnewski N, Loddenkemper R.

Gesundheitswesen. 2012 Jun;74(6):337-50. doi: 10.1055/s-0032-1306680. Epub 2012 Jun 21. German.

PMID:
22723258
23.

Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting.

Feuerriegel S, Oberhauser B, George AG, Dafae F, Richter E, Rüsch-Gerdes S, Niemann S.

BMC Microbiol. 2012 May 30;12:90. doi: 10.1186/1471-2180-12-90.

24.

[International Standards of Tuberculosis Care (ISTC)--comments from the German point of view].

Castell S, Bauer T, Diel R, Hedrich A, Magdorf K, Rüsch-Gerdes S, Schaberg T, Loddenkemper R; World Health Organization.

Pneumologie. 2012 Apr;66(4):240-9. doi: 10.1055/s-0031-1291667. Epub 2012 Mar 13. German.

25.

[Tuberculosis infection control--recommendations of the DZK].

Ziegler R, Just HM, Castell S, Diel R, Gastmeier P, Haas W, Hauer B, Loytved G, Mielke M, Moser I, Nienhaus A, Richter E, Rüden H, Rüsch-Gerdes S, Schaberg T, Wischnewski N, Loddenkemper R.

Pneumologie. 2012 May;66(5):269-82. doi: 10.1055/s-0031-1291582. Epub 2012 Jan 31. German.

26.

High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.

Sanchez-Padilla E, Dlamini T, Ascorra A, Rüsch-Gerdes S, Tefera ZD, Calain P, de la Tour R, Jochims F, Richter E, Bonnet M.

Emerg Infect Dis. 2012 Jan;18(1):29-37. doi: 10.3201/eid1801.110850.

27.

Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study.

Siddiqi S, Ahmed A, Asif S, Behera D, Javaid M, Jani J, Jyoti A, Mahatre R, Mahto D, Richter E, Rodrigues C, Visalakshi P, Rüsch-Gerdes S.

J Clin Microbiol. 2012 Feb;50(2):435-40. doi: 10.1128/JCM.05188-11. Epub 2011 Dec 7.

28.

Evaluation of Mycobacterium tuberculosis typing methods in a 4-year study in Schleswig-Holstein, Northern Germany.

Roetzer A, Schuback S, Diel R, Gasau F, Ubben T, di Nauta A, Richter E, Rüsch-Gerdes S, Niemann S.

J Clin Microbiol. 2011 Dec;49(12):4173-8. doi: 10.1128/JCM.05293-11. Epub 2011 Oct 12.

29.

Impact of Fgd1 and ddn diversity in Mycobacterium tuberculosis complex on in vitro susceptibility to PA-824.

Feuerriegel S, Köser CU, Baù D, Rüsch-Gerdes S, Summers DK, Archer JA, Marti-Renom MA, Niemann S.

Antimicrob Agents Chemother. 2011 Dec;55(12):5718-22. doi: 10.1128/AAC.05500-11. Epub 2011 Sep 19.

30.

Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection.

Bonnet M, Pardini M, Meacci F, Orrù G, Yesilkaya H, Jarosz T, Andrew PW, Barer M, Checchi F, Rinder H, Orefici G, Rüsch-Gerdes S, Fattorini L, Oggioni MR, Melzer J, Niemann S, Varaine F.

PLoS One. 2011;6(8):e23081. doi: 10.1371/journal.pone.0023081. Epub 2011 Aug 23.

31.

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update.

Falzon D, Jaramillo E, Schünemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, Fitzpatrick C, Gebhard A, Getahun H, Henkens M, Holtz TH, Keravec J, Keshavjee S, Khan AJ, Kulier R, Leimane V, Lienhardt C, Lu C, Mariandyshev A, Migliori GB, Mirzayev F, Mitnick CD, Nunn P, Nwagboniwe G, Oxlade O, Palmero D, Pavlinac P, Quelapio MI, Raviglione MC, Rich ML, Royce S, Rüsch-Gerdes S, Salakaia A, Sarin R, Sculier D, Varaine F, Vitoria M, Walson JL, Wares F, Weyer K, White RA, Zignol M.

Eur Respir J. 2011 Sep;38(3):516-28. doi: 10.1183/09031936.00073611. Epub 2011 Aug 4.

32.

Variant G57E of mannose binding lectin associated with protection against tuberculosis caused by Mycobacterium africanum but not by M. tuberculosis.

Thye T, Niemann S, Walter K, Homolka S, Intemann CD, Chinbuah MA, Enimil A, Gyapong J, Osei I, Owusu-Dabo E, Rüsch-Gerdes S, Horstmann RD, Ehlers S, Meyer CG.

PLoS One. 2011;6(6):e20908. doi: 10.1371/journal.pone.0020908. Epub 2011 Jun 10.

33.

Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system.

Hillemann D, Rüsch-Gerdes S, Boehme C, Richter E.

J Clin Microbiol. 2011 Apr;49(4):1202-5. doi: 10.1128/JCM.02268-10. Epub 2011 Jan 26.

34.

Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains.

Macheras E, Roux AL, Bastian S, Leão SC, Palaci M, Sivadon-Tardy V, Gutierrez C, Richter E, Rüsch-Gerdes S, Pfyffer G, Bodmer T, Cambau E, Gaillard JL, Heym B.

J Clin Microbiol. 2011 Feb;49(2):491-9. doi: 10.1128/JCM.01274-10. Epub 2010 Nov 24.

35.

Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistance.

Feuerriegel S, Köser C, Trübe L, Archer J, Rüsch Gerdes S, Richter E, Niemann S.

Antimicrob Agents Chemother. 2010 Nov;54(11):4794-8. doi: 10.1128/AAC.00738-10. Epub 2010 Aug 30.

36.

Drug-susceptibility testing in TB: current status and future prospects.

Richter E, Rüsch-Gerdes S, Hillemann D.

Expert Rev Respir Med. 2009 Oct;3(5):497-510. doi: 10.1586/ers.09.45.

PMID:
20477339
37.

embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation.

Plinke C, Cox HS, Zarkua N, Karimovich HA, Braker K, Diel R, Rüsch-Gerdes S, Feuerriegel S, Niemann S.

J Antimicrob Chemother. 2010 Jul;65(7):1359-67. doi: 10.1093/jac/dkq120. Epub 2010 Apr 28.

PMID:
20427375
38.

[Significance of local and general risk factors for the pathogenesis of pulmonary, non-tuberculous mycobacteriosis in non-AIDS patients].

Matthiessen W, Schmidt C, Rüsch-Gerdes S, Schönfeld N.

Pneumologie. 2010 May;64(5):281-90. doi: 10.1055/s-0029-1244069. Epub 2010 Apr 23. German.

39.

Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results.

Plinke C, Cox HS, Kalon S, Doshetov D, Rüsch-Gerdes S, Niemann S.

Tuberculosis (Edinb). 2009 Nov;89(6):448-52. doi: 10.1016/j.tube.2009.09.001. Epub 2009 Oct 2.

PMID:
19800845
40.

Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results.

Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, Rigouts L, Rüsch-Gerdes S, Wright A.

J Clin Microbiol. 2009 Nov;47(11):3501-6. doi: 10.1128/JCM.01209-09. Epub 2009 Sep 16.

41.

Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains.

Intemann CD, Thye T, Niemann S, Browne EN, Amanua Chinbuah M, Enimil A, Gyapong J, Osei I, Owusu-Dabo E, Helm S, Rüsch-Gerdes S, Horstmann RD, Meyer CG.

PLoS Pathog. 2009 Sep;5(9):e1000577. doi: 10.1371/journal.ppat.1000577. Epub 2009 Sep 11.

42.

Liquid culture for Mycobacterium tuberculosis: proceed, but with caution.

Anthony RM, Cobelens FG, Gebhard A, Klatser PR, Lumb R, Rüsch-Gerdes S, van Soolingen D.

Int J Tuberc Lung Dis. 2009 Sep;13(9):1051-3.

PMID:
19723391
43.

CTLA4 autoimmunity-associated genotype contributes to severe pulmonary tuberculosis in an African population.

Thye T, Scarisbrick G, Browne EN, Chinbuah MA, Gyapong J, Osei I, Owusu-Dabo E, Niemann S, Rüsch-Gerdes S, Meyer CG, Horstmann RD.

PLoS One. 2009 Jul 17;4(7):e6307. doi: 10.1371/journal.pone.0006307.

44.

Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe.

Pardini M, Niemann S, Varaine F, Iona E, Meacci F, Orrù G, Yesilkaya H, Jarosz T, Andrew P, Barer M, Checchi F, Rinder H, Orefici G, Rüsch-Gerdes S, Fattorini L, Oggioni MR, Bonnet M.

Tuberculosis (Edinb). 2009 Jul;89(4):317-24. doi: 10.1016/j.tube.2009.04.002. Epub 2009 Jun 17.

PMID:
19539531
45.

Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.

Feuerriegel S, Cox HS, Zarkua N, Karimovich HA, Braker K, Rüsch-Gerdes S, Niemann S.

Antimicrob Agents Chemother. 2009 Aug;53(8):3353-6. doi: 10.1128/AAC.00050-09. Epub 2009 May 26.

46.

IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB.

Thye T, Browne EN, Chinbuah MA, Gyapong J, Osei I, Owusu-Dabo E, Brattig NW, Niemann S, Rüsch-Gerdes S, Horstmann RD, Meyer CG.

PLoS One. 2009;4(5):e5420. doi: 10.1371/journal.pone.0005420. Epub 2009 May 1.

47.

Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens.

Hillemann D, Rüsch-Gerdes S, Richter E.

J Clin Microbiol. 2009 Jun;47(6):1767-72. doi: 10.1128/JCM.00081-09. Epub 2009 Apr 22.

48.

Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.

Cox HS, Sibilia K, Feuerriegel S, Kalon S, Polonsky J, Khamraev AK, Rüsch-Gerdes S, Mills C, Niemann S.

N Engl J Med. 2008 Nov 27;359(22):2398-400. doi: 10.1056/NEJMc0805644. No abstract available. Erratum in: N Engl J Med. 2010 Oct 21;363(17):1682.

49.

Single-nucleotide polymorphisms in Rv2629 are specific for Mycobacterium tuberculosis genotypes Beijing and Ghana but not associated with rifampin resistance.

Homolka S, Köser C, Archer J, Rüsch-Gerdes S, Niemann S.

J Clin Microbiol. 2009 Jan;47(1):223-6. doi: 10.1128/JCM.01237-08. Epub 2008 Nov 19.

50.

Origin, spread and demography of the Mycobacterium tuberculosis complex.

Wirth T, Hildebrand F, Allix-Béguec C, Wölbeling F, Kubica T, Kremer K, van Soolingen D, Rüsch-Gerdes S, Locht C, Brisse S, Meyer A, Supply P, Niemann S.

PLoS Pathog. 2008 Sep 19;4(9):e1000160. doi: 10.1371/journal.ppat.1000160.

Supplemental Content

Loading ...
Support Center